Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Neil, McCartan"'
Autor:
Joshua Bridge, Muhieddine Labban, Alexander P. Cole, Busola Adebusoye, Sarah C. Smith, Evangelia Protopapa, Neil McCartan, Chris Brew-Graves, Quoc-Dien Trinh, Kevin Hamer, Sue Mallett, Jan van der Meulen, Caroline M. Moore
Publikováno v:
European Urology Open Science, Vol 64, Iss , Pp 11-21 (2024)
Background and objective: Radical prostatectomy (RP) is an established treatment for localised prostate cancer that can have a significant impact on urinary and sexual function, with recovery over time. Our aim was to describe functional recovery in
Externí odkaz:
https://doaj.org/article/e0ec0079ce144c8498cfe42b7758e6c0
Autor:
Mieke Van Hemelrijck, Chris Brew-Graves, Neil McCartan, Louise Brown, Manuel Rodriguez-Justo, Aiman Haider, Alex Freeman, Mark Emberton, Kingshuk Pal, William Maynard, Aida Santaolalla, Nora Pashayan, Malcolm Mason, Tom Syer, Chris Parker, Caroline M Moore, Charlotte Bevan, Jayshireen Singh, Stuart Mackay-Thomas, Kate Walters, Mehul Mathukia, Charlotte Moss, David Sharpe, Kinnari Naik, Thomas Callender, Andrew Feber, Lee Berney, Anwar Padhani, Shonit Punwani, Hashim U Ahmed, Richard Kaplan, Teresa Marsden, Joanna Hadley, Steve Tuck, Saran Green, Ton Coolen, Elizabeth Isaac, Giorgio Brembilla, Douglas Kopcke, Francesco Giganti, Gerhardt Attard, Hina Pervez, Eric Aboagye, Elena Frangou, Fiona Gong, Louise C Brown, Aida Santa Olalla, Rosie Clow, Ged Corbett, Anna Wingate, Fatima Akbar, Suparna Thakali, Ashling Henderson, Dizem Tekin, Joey Clement, Harbit Sidhu, Teresita Beeston, Katerina Soteriou, Francesca Rawlins, Pirruntha Sivaharan, Savahnna Wolfe, Henry Tam, Heather Bholastewart, Sarp Keskin, Mariana Bertoncelli, Paul Boutros, Hayley Whitaker, Caroline Dive, Eytan Domany, Peter Parker, Andrew Prugia, Claire Chalmers-Watson, Alexander Gilkes, Dr Hira
Publikováno v:
BMJ Oncology, Vol 2, Iss 1 (2023)
Objective In men with a raised prostate-specific antigen (PSA), MRI increases the detection of clinically significant cancer and reduces overdiagnosis, with fewer biopsies. MRI as a screening tool has not been assessed independently of PSA in a forma
Externí odkaz:
https://doaj.org/article/9e67b1d6c59a4ab9a2b0588957b411c1
Autor:
Joseph M. Norris, Lucy A.M. Simmons, Abi Kanthabalan, Alex Freeman, Neil McCartan, Caroline M. Moore, Shonit Punwani, Hayley C. Whitaker, Mark Emberton, Hashim U. Ahmed
Publikováno v:
European Urology Open Science, Vol 30, Iss , Pp 16-24 (2021)
Background: Multiparametric magnetic resonance imaging (mpMRI) has improved risk stratification for suspected prostate cancer in patients following prior biopsy. However, not all significant cancers are detected by mpMRI. The PICTURE study provides t
Externí odkaz:
https://doaj.org/article/6fb66e04361447c0921bc1523a629cb0
Autor:
Teresa Marsden, Neil McCartan, Louise Brown, Manuel Rodriguez-Justo, Tom Syer, Giorgio Brembilla, Mieke Van Hemelrijck, Ton Coolen, Gerhardt Attard, Shonit Punwani, Caroline M. Moore, Hashim U. Ahmed, Mark Emberton, on behalf of the ReIMAGINE Study Group
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
Introduction The ReIMAGINE Consortium was conceived to develop risk-stratification models that might incorporate the full range of novel prostate cancer (PCa) diagnostics (both commercial and academic). Methods ReIMAGINE Risk is an ethics approved (1
Externí odkaz:
https://doaj.org/article/d0329a3773974d5096b7bb9882849cb0
Autor:
Aida Santaolalla, Tim Hulsen, Jenson Davis, Hashim U. Ahmed, Caroline M. Moore, Shonit Punwani, Gert Attard, Neil McCartan, Mark Emberton, Anthony Coolen, Mieke Van Hemelrijck
Publikováno v:
Frontiers in Artificial Intelligence, Vol 4 (2021)
Introduction. Prostate cancer (PCa) is the most frequent cancer diagnosis in men worldwide. Our ability to identify those men whose cancer will decrease their lifespan and/or quality of life remains poor. The ReIMAGINE Consortium has been established
Externí odkaz:
https://doaj.org/article/558a9d5bd1d349c78ec70ece4a74dcf3
Autor:
Mieke Van Hemelrijck, Neil McCartan, Louise Brown, Mark Emberton, Aida Santaolalla, Charlotte Louise Moss, Caroline M Moore, Anna Haire, Shonit Punwani, Teresa Marsden, Derek J Lomas, Joanna Hadley, Steve Tuck, Saran Green, Ton Coolen, Elizabeth Isaac, Giorgio Brembilla, Douglas Kopcke, Francesco Giganti, Harbir Sidhu
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
Introduction The primary objective of the ReIMAGINE Prostate Cancer Screening Study is to explore the uptake of an invitation to prostate cancer screening using MRI.Methods and analysis The ReIMAGINE Prostate Cancer Screening Study is a prospective s
Externí odkaz:
https://doaj.org/article/2d020bf82ef2425ebb101ba2e49a621f
Autor:
Deepika Reddy, Max Peters, Marieke Van Son, Mariana Bertoncelli Tanaka, Philipp Huber, Derek Lomas, Arnas Rakauskas, Saiful Miah, David Eldred-Evans, Emma Cullen, Tim Dudderidge, Stuart McCracken, Damian Greene, Raj Nigam, Neil McCartan, Massimo Valerio, Clement Orczyk, Jaspal Virdi, Manit Arya, Taimur Shah, Hashim Ahmed
Publikováno v:
Journal of Urology. 209
Autor:
Rachael Rodell, Neil McCartan, Clement Orczyk, Mark Emberton, Hashim U. Ahmed, Chris Brew-Graves, Alex Freeman, Navin Ramachandran, Norman R. Williams, Ingrid Potyka, Yipeng Hu, Dean C. Barratt
Publikováno v:
Journal of Urology. 205:1090-1099
We determined the early efficacy of bipolar radiofrequency ablation with a coil design for focal ablation of clinically significant localized prostate cancer visible at multiparametric magnetic resonance imaging.A prospective IDEAL phase 2 developmen
Autor:
Feargus Hosking-Jervis, Henry Lewi, Chris Ogden, Max Peters, Suks Minhas, Daniel Ball, Deepika Reddy, Saiful Miah, Hashim U. Ahmed, Damian Greene, Raj Persad, Naveed Afzal, Enrique Gómez Gómez, Caroline M. Moore, M. Valerio, Peter S.N. van Rossum, Stuart McCracken, David Eldred Evans, Neil McCartan, Richard Hindley, Mathias Winkler, Mark Emberton, Taimur T. Shah, Na Hyun Kim, Raj Nigam, Stephanie Guillaumier, Jaspal Virdi, A. Emara, Tim Dudderidge, Manit Arya, Marieke J. van Son
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:567-574
Focal therapy (FT) ablates areas of prostate cancer rather than treating the whole gland. We compared oncological outcomes of FT to radical prostatectomy (RP). Using prospective multicentre databases of 761 FT and 572 RP cases (November/2005-Septembe
Autor:
Deepika Reddy, Max Peters, Taimur Shah, Marieke van Son, Mariana Tanaka Bertoncelli, Philipp Huber, Derek Lomas, Arnas Rakauskas, Saiful Miah, David Eldred-Evans, Stephanie Guillaumier, Feargus Hosking-Jervis, Ryan Engle, Tim Dudderidge, Richard Hindley, Amr Emara, Raj Nigam, Neil McCartan, Massimo Valerio, Naveed Afzal, Henry Lewi, Clement Orczyk, Chris Ogden, Iqbal Shergill, Raj Persad, Jaspal Virdi, Stuart McCracken, Damian Greene, Caroline Moore, Manit Arya, Mathias Winkler, Mark Emberton, Hashim Ahmed
Publikováno v:
Journal of Urology. 207